{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:45:58Z","timestamp":1790844358583,"version":"4.1.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T00:00:00Z","timestamp":1594252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T00:00:00Z","timestamp":1594252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000774","name":"Newcastle University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000774","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Purpose of Review<\/jats:title><jats:p>The most serious DNA damage, DNA double strand breaks (DNA-dsb), leads to mutagenesis, carcinogenesis or apoptosis if left unrepaired. Non-homologous end joining (NHEJ) is the principle repair pathway employed by mammalian cells to repair DNA-dsb. Several proteins are involved in this pathway, defects in which can lead to human disease. This review updates on the most recent information available for the specific diseases associated with the pathway.<\/jats:p><\/jats:sec><jats:sec><jats:title>Recent Findings<\/jats:title><jats:p>A new member of the NHEJ pathway, PAXX, has been identified, although no human disease has been associated with it. The clinical phenotypes of Artemis, DNA ligase 4, Cernunnos-XLF and DNA-PKcs deficiency have been extended. The role of haematopoietic stem cell transplantation, following reduced intensity conditioning chemotherapy, for many of these diseases is being advanced.<\/jats:p><\/jats:sec><jats:sec><jats:title>Summary<\/jats:title><jats:p>In the era of newborn screening, urgent genetic diagnosis is necessary to correctly target appropriate treatment for patients with DNA-dsb repair disorders.<\/jats:p><\/jats:sec>","DOI":"10.1007\/s11882-020-00955-z","type":"journal-article","created":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T07:37:50Z","timestamp":1594280270000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Update on DNA-Double Strand Break Repair Defects in Combined Primary Immunodeficiency"],"prefix":"10.1007","volume":"20","author":[{"given":"Mary A.","family":"Slatter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Gennery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,9]]},"reference":[{"key":"955_CR1","doi-asserted-by":"crossref","unstructured":"Gennery A. Recent advances in understanding RAG deficiencies. F1000Res. 2019;8. pii: F1000 Faculty Rev-148.","DOI":"10.12688\/f1000research.17056.1"},{"key":"955_CR2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrg1746","volume":"7","author":"M O\u2019Driscoll","year":"2006","unstructured":"O\u2019Driscoll M, Jeggo PA. The role of double-strand break repair \u2013 insights from human genetics. Nat Rev Genet. 2006;7:45\u201354.","journal-title":"Nat Rev Genet"},{"key":"955_CR3","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12943-019-1100-5","volume":"18","author":"L Bian","year":"2019","unstructured":"Bian L, Meng Y, Zhang M, Li D. MRE11-RAD50-NBS1 complex alterations and DNA damage response: implications for cancer treatment. Mol Cancer. 2019;18:169.","journal-title":"Mol Cancer"},{"key":"955_CR4","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/hmg\/ddi027","volume":"14","author":"M Fernet","year":"2005","unstructured":"Fernet M, Gribaa M, Salih MAM, Seidahmed MZ, Hall J, Koenig M. Identification and functional consequences of a novel MRE11 mutation affecting 10 Saudi Arabian patients with the ataxia telangiectasia-like disorder. Hum Molec Genet. 2005;14:307\u201318.","journal-title":"Hum Molec Genet"},{"key":"955_CR5","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1093\/hmg\/ddh221","volume":"13","author":"D Delia","year":"2004","unstructured":"Delia D, Piane M, Buscemi G, Savio C, Palmeri S, Lulli P, et al. MRE11 mutations and impaired ATM-dependent responses in an Italian family with ataxia-telangiectasia -like disorder. Hum Molec Genet. 2004;13:2155\u201363.","journal-title":"Hum Molec Genet"},{"key":"955_CR6","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0092-8674(00)81547-0","volume":"99","author":"GS Stewart","year":"1999","unstructured":"Stewart GS, Maser RS, Stankovic T, Bressan DA, Kaplan MI, Jaspers NGJ, et al. The DNA double-strand break repair gene hMRE11 is mutated in individuals with an ataxia-telangiectasia-like disorder. Cell. 1999;99:577\u201387.","journal-title":"Cell"},{"key":"955_CR7","doi-asserted-by":"crossref","unstructured":"\u2022 Ragamin A, Yigit G, Bousset K, Beleggia F, Verheijen FW, de Wit MY, et al. Human RAD50 deficiency: Confirmation of a distinctive phenotype. Am J Med Genet A. 2020 (in press). An important description of the second reported patient with RAD50 deficiency.","DOI":"10.1002\/ajmg.a.61570"},{"key":"955_CR8","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ajhg.2009.04.010","volume":"84","author":"R Waltes","year":"2009","unstructured":"Waltes R, Kalb R, Gatei M, Kijas AW, Stumm M, Sobeck A, et al. Human RAD50 deficiency in a Nijmegen breakage syndrome-like disorder. Am J Hum Genet. 2009;84:605\u201316.","journal-title":"Am J Hum Genet"},{"key":"955_CR9","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.molcel.2017.05.015","volume":"66","author":"AN Blackford","year":"2017","unstructured":"Blackford AN, Jackson SP. ATM, ATR, and DNA-PK: the trinity at the heart of the DNA damage response. Mol Cell. 2017;66:801\u201317.","journal-title":"Mol Cell"},{"key":"955_CR10","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.molcel.2004.10.029","volume":"16","author":"E Riballo","year":"2004","unstructured":"Riballo E, Kuhne M, Rief N, Doherty A, Smith GCM, Recio MJ, et al. A pathway of double-strand break rejoining dependent upon ATM, Artemis, and proteins locating to gamma-H2AX foci. Mol Cell. 2004;16:715\u201324.","journal-title":"Mol Cell"},{"key":"955_CR11","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1042\/BST20180518","volume":"47","author":"Q Wu","year":"2019","unstructured":"Wu Q. Structural mechanism of DNA-end synapsis in the non-homologous end joining pathway for repairing double-strand breaks: bridge over troubled ends. Biochem Soc Trans. 2019;47:1609\u201319.","journal-title":"Biochem Soc Trans"},{"key":"955_CR12","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1126\/science.1261971","volume":"347","author":"T Ochi","year":"2015","unstructured":"\u2022\u2022 Ochi T, Blackford AN, Coates J, Jhujh S, Mehmood S, Tamura N, et al. PAXX, a paralog of XRCC4 and XLF, interacts with Ku to promote DNA double-strand break repair. Science. 2015;347:185\u20138 This, with reference 13 and 14, describes a new factor required for NHEJ.","journal-title":"Science"},{"key":"955_CR13","doi-asserted-by":"crossref","first-page":"6233","DOI":"10.1038\/ncomms7233","volume":"6","author":"M Xing","year":"2015","unstructured":"\u2022\u2022 Xing M, Yang M, Huo W, Feng F, Wei L, Jiang W, et al. Interactome analysis identifies a new paralogue of XRCC4 in non-homologous end joining DNA repair pathway. Nat Commun. 2015;6:6233 This, with reference 12 and 14, describes a new factor required for NHEJ.","journal-title":"Nat Commun"},{"key":"955_CR14","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/cdd.2015.22","volume":"22","author":"A Craxton","year":"2015","unstructured":"\u2022\u2022 Craxton A, Somers J, Munnur D, Jukes-Jones R, Cain K, Malewicz M. XLS (c9orf142) is a new component of mammalian DNA double-stranded break repair. Cell Death Differ. 2015;22:890\u20137 This, with reference 12 and 13, describes a new factor required for NHEJ.","journal-title":"Cell Death Differ"},{"key":"955_CR15","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0092-8674(01)00309-9","volume":"105","author":"D Moshous","year":"2001","unstructured":"Moshous D, Callebaut I, de Chasseval R, Corneo B, Cavazzana-Calvo M, Le Deist F, et al. Artemis, a novel DNA double-strand break repair\/V(D)J recombination protein, is mutated in human severe combined immune deficiency. Cell. 2001;105:177\u201386.","journal-title":"Cell"},{"key":"955_CR16","first-page":"669","volume":"63","author":"JF Jones","year":"1991","unstructured":"Jones JF, Ritenbaugh CK, Spence MA, Hayward A. Severe combined immunodeficiency among the Navajo. I. Characterization of phenotypes, epidemiology, and population genetics. Hum Biol. 1991;63:669\u201382.","journal-title":"Hum Biol"},{"key":"955_CR17","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00431-011-1452-3","volume":"170","author":"M van der Burg","year":"2011","unstructured":"van der Burg M, Gennery AR. Educational paper. The expanding clinical and immunological spectrum of severe combined immunodeficiency. Eur J Pediatr. 2011;170:561\u201371.","journal-title":"Eur J Pediatr"},{"key":"955_CR18","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.molimm.2013.05.004","volume":"56","author":"IY Bajin","year":"2013","unstructured":"\u2022 Bajin IY, Ayvaz DC, \u00dcnal S, \u00d6zg\u00fcr TT, \u00c7etin M, G\u00fcmr\u00fck F, et al. Atypical Combined Immunodeficiency Due to Artemis Defect: A Case Presenting as Hyperimmunoglobulin M Syndrome and With LGLL. Mol Immunol. 2013;56:354\u20137 A description of Artemis deficiency with hyper IgM, expanding the clinical phenotype.","journal-title":"Mol Immunol"},{"key":"955_CR19","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.1182\/blood-2004-12-4861","volume":"105","author":"M Ege","year":"2005","unstructured":"Ege M, Ma Y, Manfras B, Kalwak K, Lu H, Lieber MR, et al. Omenn syndrome due to ARTEMIS mutations. Blood. 2005;105:4179\u201386.","journal-title":"Blood"},{"key":"955_CR20","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1172\/JCI16774","volume":"111","author":"D Moshous","year":"2003","unstructured":"Moshous D, Pannetier C, de Chasseval R, le Deist F, Cavazzana-Calvo M, Romana S, et al. Partial T and B lymphocyte immunodeficiency and predisposition to lymphoma in patients with hypomorphic mutations in Artemis. J Clin Invest. 2003;111:381\u20137.","journal-title":"J Clin Invest"},{"key":"955_CR21","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/hmg\/ddl050","volume":"15","author":"PM Evans","year":"2006","unstructured":"Evans PM, Woodbine L, Riballo E, Gennery AR, Hubank M, Jeggo PA. Radiation-induced delayed cell death in a hypomorphic Artemis cell line. Hum Mol Genet. 2006;15:1303\u201311.","journal-title":"Hum Mol Genet"},{"key":"955_CR22","doi-asserted-by":"crossref","first-page":"7361","DOI":"10.1093\/hmg\/ddv437","volume":"24","author":"T Volk","year":"2015","unstructured":"Volk T, Pannicke U, Reisli I, Bulashevska A, Ritter J, Bj\u00f6rkman A, et al. DCLRE1C (ARTEMIS) mutations causing phenotypes ranging from atypical severe combined immunodeficiency to mere antibody deficiency. Hum Mol Genet. 2015;24:7361\u201372.","journal-title":"Hum Mol Genet"},{"key":"955_CR23","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.clim.2013.08.006","volume":"149","author":"PP Lee","year":"2013","unstructured":"Lee PP, Woodbine L, Gilmour KC, Bibi S, Cale CM, Amrolia PJ, et al. The many faces of Artemis-deficient combined immunodeficiency - two patients with DCLRE1C mutations and a systematic literature review of genotype-phenotype correlation. Clin Immunol. 2013;149:464\u201374.","journal-title":"Clin Immunol"},{"key":"955_CR24","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jaci.2015.03.005","volume":"136","author":"K Felgentreff","year":"2015","unstructured":"Felgentreff K, Lee YN, Frugoni F, Du L, van der Burg M, Giliani S, et al. Functional analysis of naturally occurring DCLRE1C mutations and correlation with the clinical phenotype of ARTEMIS deficiency. J Allergy Clin Immunol. 2015;136:140\u2013150.e7.","journal-title":"J Allergy Clin Immunol"},{"key":"955_CR25","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1182\/blood-2010-08-300384","volume":"117","author":"L Brown","year":"2011","unstructured":"Brown L, Xu-Bayford J, Allwood Z, Slatter M, Cant A, Davies EG, et al. Neonatal diagnosis of severe combined immunodeficiency leads to significantly improved survival outcome: the case for newborn screening. Blood. 2011;117:3243\u20136.","journal-title":"Blood"},{"key":"955_CR26","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1056\/NEJMoa1401177","volume":"371","author":"S-Y Pai","year":"2014","unstructured":"Pai S-Y, Logan BR, Griffith LM, Buckley RH, Parrott RE, Dvorak CC, et al. Transplantation outcomes for severe combined immunodeficiency, 2000\u20132009. N Engl J Med. 2014;371:434\u201346.","journal-title":"N Engl J Med"},{"key":"955_CR27","doi-asserted-by":"crossref","unstructured":"Kwan A, Abraham RS, Currier R, Brower A, Andruszewski K, Abbott JK, et al. Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States. JAMA. 2014;312:729\u201338.","DOI":"10.1001\/jama.2014.9132"},{"key":"955_CR28","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.jaci.2014.02.042","volume":"133","author":"A Hassan","year":"2014","unstructured":"Hassan A, Lee P, Maggina P, Xu JH, Moreira D, Slatter M, et al. Host natural killer immunity is a key indicator of permissiveness for donor cell engraftment in patients with severe combined immunodeficiency. J Allergy Clin Immunol. 2014;133:1660\u20136.","journal-title":"J Allergy Clin Immunol"},{"key":"955_CR29","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.jaci.2014.06.021","volume":"134","author":"CC Dvorak","year":"2014","unstructured":"Dvorak CC, Hassan A, Slatter MA, H\u00f6nig M, Lankester AC, Buckley RH, et al. Comparison of outcomes of hematopoietic stem cell transplantation without chemotherapy conditioning by using matched sibling and unrelated donors for treatment of severe combined immunodeficiency. J Allergy Clin Immunol. 2014;134:935\u2013943.e15.","journal-title":"J Allergy Clin Immunol"},{"key":"955_CR30","doi-asserted-by":"crossref","unstructured":"Abd Hamid IJ, Slatter MA, McKendrick F, Pearce MS, Gennery AR. Long-Term Health Outcome and Quality of Life Post-HSCT for IL7R\u03b1-, Artemis-, RAG1- and RAG2-Deficient Severe Combined Immunodeficiency: a Single Center Report. J Clin Immunol. 2018;38:727\u201332.","DOI":"10.1007\/s10875-018-0540-9"},{"key":"955_CR31","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1182\/blood-2013-01-476432","volume":"123","author":"C Schuetz","year":"2014","unstructured":"Schuetz C, Neven B, Dvorak CC, Leroy S, Ege MJ, Pannicke U, et al. SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID. Blood. 2014;123:281\u20139.","journal-title":"Blood"},{"key":"955_CR32","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1182\/blood-2018-03-840702","volume":"132","author":"E Haddad","year":"2018","unstructured":"\u2022 Haddad E, Logan BR, Griffith LM, Buckley RH, Parrott RE, Prockop SE, et al. SCID Genotype and 6-month Posttransplant CD4 Count Predict Survival and Immune Recovery. Blood. 2018;132:1737\u201349 An important observation regarding patients with Artemis-SCID, which suggests for the first time that early post-transplant mortality is higher than for RAG-SCID, possibly implicating the chemotherapy conditioning.","journal-title":"Blood"},{"key":"955_CR33","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Punwani D, Kawahara M, Yu J, Sanford U, Roy S, Patel K, et al. Lentivirus Mediated Correction of Artemis-Deficient Severe Combined Immunodeficiency. Hum Gene Ther. 2017;28:112\u201324 With reference 34, this describes lentiviral gene therapy as a potential treatment for Artemis-SCID.","DOI":"10.1089\/hum.2016.064"},{"key":"955_CR34","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Charrier S, Lagresle-Peyrou C, Poletti V, Rothe M, C\u00e9drone G, Gjata B, et al. Biosafety Studies of a Clinically Applicable Lentiviral Vector for the Gene Therapy of Artemis-SCID. Mol Ther Methods Clin Dev. 2019;15:232\u201345 With reference 33, this describes lentiviral gene therapy as a potential treatment for Artemis-SCID.","DOI":"10.1016\/j.omtm.2019.08.014"},{"key":"955_CR35","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1016\/j.bbmt.2018.12.172","volume":"25","author":"R Agarwal","year":"2019","unstructured":"Agarwal R, Dvorak CC, Proshaska S, Long-Boyle J, Kwon H-S, Brown JM, et al. Toxicity-free hematopoietic stem cell engraftment achieved with anti-CD117 monoclonal antibody conditioning. Biol Blood Marrow Transplant. 2019;25:S92.","journal-title":"Biol Blood Marrow Transplant"},{"key":"955_CR36","doi-asserted-by":"crossref","unstructured":"van Os NJH, Haaxma CA, van der Flier M, Merkus PJFM, van Deuren M, de Groot IJM, et al. Ataxia-telangiectasia: recommendations for multidisciplinary treatment. Dev Med Child Neurol. 2017:59680\u20139.","DOI":"10.1111\/dmcn.13424"},{"key":"955_CR37","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0022-3476(00)70106-5","volume":"136","author":"MA Lefton-Greif","year":"2000","unstructured":"Lefton-Greif MA, Crawford TO, Winkelstein JA, Loughlin GM, Koerner CB, Zahurak M, et al. Oropharyngeal dysphagia and aspiration in patients with ataxia-telangiectasia. J Pediatr. 2000;136:225\u201331.","journal-title":"J Pediatr"},{"key":"955_CR38","first-page":"208","volume":"46","author":"O Sanal","year":"2004","unstructured":"Sanal O, Ozba\u015f-Ger\u00e7eker F, Yel L, Ersoy F, Tezcan I, Berkel AI, et al. Defective anti-polysaccharide antibody response in patients with ataxia-telangiectasia. Turk J Pediatr. 2004;46:208\u201313.","journal-title":"Turk J Pediatr"},{"key":"955_CR39","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1084\/jem.20041162","volume":"200","author":"B Reina-San-Martin","year":"2004","unstructured":"Reina-San-Martin B, Chen HT, Nussenzweig A, Nussenzweig MC. ATM is required for efficient recombination between immunoglobulin switch regions. J Exp Med. 2004;200:1103\u201310.","journal-title":"J Exp Med"},{"key":"955_CR40","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s12887-018-1156-1","volume":"18","author":"A Krauthammerr","year":"2018","unstructured":"Krauthammerr A, Lahad A, Goldberg L, Sarouk I, Weiss B, Somech R, et al. Elevated IgM levels as a marker for a unique phenotype in patients with Ataxia telangiectasia. BMC Pediatr. 2018;18:185.","journal-title":"BMC Pediatr"},{"key":"955_CR41","doi-asserted-by":"crossref","unstructured":"Amirifar P, Mozdarani H, Yazdani R, Kiaei F, Moeini Shad T, Shahkarami S, et al. Effect of Class Switch Recombination Defect on the Phenotype of Ataxia-Telangiectasia Patients. Immunol Invest 2020 (in Press).","DOI":"10.1080\/08820139.2020.1723104"},{"key":"955_CR42","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/1097-0142(20010801)92:3<479::AID-CNCR1346>3.0.CO;2-G","volume":"92","author":"SN Teraoka","year":"2001","unstructured":"Teraoka SN, Malone KE, Doody DR, Suter NM, Ostrander EA, Daling JR, et al. Increased frequency of ATM mutations in breast carcinoma patients with early onset disease and positive family history. Cancer. 2001;92:479\u201387.","journal-title":"Cancer"},{"key":"955_CR43","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s13023-016-0543-7","volume":"11","author":"C Rothblum-Oviatt","year":"2016","unstructured":"Rothblum-Oviatt C, Wright J, Lefton-Greif MA, McGrath-Morrow SA, Crawford TO, Lederman HM. Ataxia telangiectasia: a review. Orphanet J Rare Dis. 2016;11:159.","journal-title":"Orphanet J Rare Dis"},{"key":"955_CR44","doi-asserted-by":"crossref","first-page":"103630","DOI":"10.1016\/j.ejmg.2019.02.003","volume":"63","author":"E Suspitsin","year":"2020","unstructured":"Suspitsin E, Sokolenko A, Bizin I, Tumakova A, Guseva M, Sokolova N, et al. ATM mutation spectrum in Russian children with ataxia-telangiectasia. Eur J Med Genet. 2020;63:103630.","journal-title":"Eur J Med Genet"},{"key":"955_CR45","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pediatrneurol.2007.03.002","volume":"37","author":"M Moin","year":"2007","unstructured":"Moin M, Aghamohammadi A, Kouhi A, Tavassoli S, Rezaei N, Ghaffari SR, et al. Ataxia-telangiectasia in Iran: clinical and laboratory features of 104 patients. Pediatr Neurol. 2007;37:21\u20138.","journal-title":"Pediatr Neurol"},{"key":"955_CR46","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1200\/JCO.2014.56.5101","volume":"33","author":"F Suarez","year":"2015","unstructured":"\u2022 Suarez F, Mahlaoui N, Canioni D, Andriamanga C, Dubois d'Enghien C, Brousse N, et al. Incidence, presentation, and prognosis of malignancies in ataxia-telangiectasia: a report from the French national registry of primary immune deficiencies. J Clin Oncol. 2015;33:202\u20138 An important manuscript detailing malignancies in the French A-T population.","journal-title":"J Clin Oncol"},{"key":"955_CR47","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1136\/adc.2006.094268","volume":"91","author":"TO Crawford","year":"2006","unstructured":"Crawford TO, Skolasky RL, Fernandez R, Rosquist KJ, Lederman HM. Survival probability in ataxia telangiectasia. Arch Dis Child. 2006;91:610\u20131.","journal-title":"Arch Dis Child"},{"key":"955_CR48","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1007\/s00415-019-09641-1","volume":"267","author":"NJH van Os","year":"2020","unstructured":"\u2022\u2022 van Os NJH, van Deuren M, Weemaes CMR, van Gaalen J, Hijdra H, Taylor AMR, et al. Classic ataxia-telangiectasia: the phenotype of long-term survivors. J Neurol. 2020;267:830\u20137 An important manuscript describing for the first time, the issues with long-term A-T survivors.","journal-title":"J Neurol"},{"key":"955_CR49","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00011-018-1142-y","volume":"67","author":"M Zaki-Dizaji","year":"2018","unstructured":"Zaki-Dizaji M, Akrami SM, Azizi G, Abolhassani H, Aghamohammadi A. Inflammation, a significant player of Ataxia-Telangiectasia pathogenesis? Inflamm Res. 2018;67:559\u201370.","journal-title":"Inflamm Res"},{"key":"955_CR50","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1186\/s12974-018-1338-7","volume":"15","author":"CW Hui","year":"2018","unstructured":"Hui CW, Song X, Ma F, Shen X, Herrup K. Ibuprofen prevents progression of ataxia telangiectasia symptoms in ATM-deficient mice. J Neuroinflammation. 2018;15:308.","journal-title":"J Neuroinflammation"},{"key":"955_CR51","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/s41375-019-0618-2","volume":"34","author":"A Riabinska","year":"2020","unstructured":"Riabinska A, Lehrmann D, Jachimowicz RD, Knittel G, Fritz C, Schmitt A, et al. ATM activity in T cells is critical for immune surveillance of lymphoma in vivo. Leukemia. 2020;34:771\u201386.","journal-title":"Leukemia"},{"key":"955_CR52","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jaci.2017.02.036","volume":"141","author":"J Slack","year":"2018","unstructured":"\u2022\u2022 Slack J, Albert MH, Balashov D, Belohradsky BH, Bertaina A, Bleesing J, et al. Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation and the European Society for Immunodeficiencies; Stem Cell Transplant for Immunodeficiencies in Europe (SCETIDE); Center for International Blood and Marrow Transplant Research; Primary Immunodeficiency Treatment Consortium. Outcome of Hematopoietic Cell Transplantation for DNA Double-Strand Break Repair Disorders. J Allergy Clin Immunol. 2018;141:322\u2013328.e10 An important manuscript demonstrating superior transplant survival following reduced intensity conditioning in a large cohort of patients with DNA-dsb repair disorders.","journal-title":"J Allergy Clin Immunol"},{"key":"955_CR53","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.3389\/fimmu.2019.02785","volume":"10","author":"R Duecker","year":"2019","unstructured":"Duecker R, Baer PC, Buecker A, Huenecke S, Pfeffermann LM, Modlich U, et al. Hematopoietic Stem Cell Transplantation Restores Na\u00efve T-Cell Populations in Atm-Deficient Mice and in Preemptively Treated Patients With Ataxia-Telangiectasia. Front Immunol. 2019;10:2785.","journal-title":"Front Immunol"},{"key":"955_CR54","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.3389\/fimmu.2018.02495","volume":"9","author":"S Bakhtiar","year":"2018","unstructured":"Bakhtiar S, Woelke S, Huenecke S, Kieslich M, Taylor AM, Schubert R, et al. Pre-emptive Allogeneic Hematopoietic Stem Cell Transplantation in Ataxia Telangiectasia. Front Immunol. 2018;9:2495.","journal-title":"Front Immunol"},{"key":"955_CR55","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1016\/j.bbmt.2018.07.001","volume":"24","author":"M Ussowicz","year":"2018","unstructured":"\u2022 Ussowicz M, Wawrzyniak-Dzier\u017cek E, Mielcarek-Siedziuk M, Salamonowicz M, Fr\u0105czkiewicz J, Rybka B, et al. Allogeneic Stem Cell Transplantation after Fanconi Anemia Conditioning in Children with Ataxia-Telangiectasia Results in Stable T Cell Engraftment and Lack of Infections despite Mixed Chimerism. Biol Blood Marrow Transplant. 2018;24:2245\u20139 A description of transplant for A-T with improved outcomes using reduced intensity conditioning.","journal-title":"Biol Blood Marrow Transplant"},{"key":"955_CR56","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.1182\/blood-2013-01-479733","volume":"122","author":"R Peffault de Latour","year":"2013","unstructured":"Peffault de Latour R, Porcher R, Dalle JH, Aljurf M, Korthof ET, Svahn J, et al. Allogeneic hematopoietic stem cell transplantation in Fanconi anemia: the European Group for Blood and Marrow Transplantation experience. Blood. 2013;122:4279\u201386.","journal-title":"Blood"},{"key":"955_CR57","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.3389\/fimmu.2019.02940","volume":"10","author":"AB Mandola","year":"2019","unstructured":"\u2022 Mandola AB, Reid B, Sirror R, Brager R, Dent P, Chakroborty P, et al. Ataxia Telangiectasia Diagnosed on Newborn Screening-Case Cohort of 5 Years' Experience. Front Immunol. 2019;10:2940 With reference 58, describes detection of newborn infants with A-T, picked up on newborn screening for SCID.","journal-title":"Front Immunol"},{"key":"955_CR58","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1007\/s10875-012-9846-1","volume":"33","author":"J Mallott","year":"2013","unstructured":"\u2022 Mallott J, Kwan A, Church J, Gonzalez-Espinosa D, Lorey F, Tang LF, et al. Newborn screening for SCID identifies patients with ataxia telangiectasia. J Clin Immunol. 2013;33:540\u20139 With reference 57, describes detection of newborn infants with A-T, picked up on newborn screening for SCID.","journal-title":"J Clin Immunol"},{"key":"955_CR59","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00431-019-03479-5","volume":"179","author":"MHD Schoenaker","year":"2020","unstructured":"\u2022\u2022 Schoenaker MHD, Blom M, de Vries MC, Weemaes CMR, van der Burg M, Willemsen MAAP. Early diagnosis of ataxia telangiectasia in the neonatal phase: a parents' perspective. Eur J Pediatr. 2020;179:251\u20136 Important manuscript reporting the opinions of parents of infants with A-T, diagnosed on newborn screening for SCID.","journal-title":"Eur J Pediatr"},{"key":"955_CR60","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.3389\/fimmu.2019.02438","volume":"10","author":"M Blom","year":"2019","unstructured":"Blom M, Schoenaker MHD, Hulst M, de Vries MC, Weemaes CMR, Willemsen MAAP, et al. Dilemma of Reporting Incidental Findings in Newborn Screening Programs for SCID: Parents' Perspective on Ataxia Telangiectasia. Front Immunol. 2019;10:2438.","journal-title":"Front Immunol"},{"key":"955_CR61","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1651-2227.1981.tb05740.x","volume":"70","author":"CM Weemaes","year":"1981","unstructured":"Weemaes CM, Hustinx TW, Scheres JM, van Munster PJ, Bakkeren JA, Taalman RD. A new chromosomal instability disorder: the Nijmegen breakage syndrome. Acta Paediatr Scand. 1981;70:557\u201364.","journal-title":"Acta Paediatr Scand"},{"key":"955_CR62","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s10875-015-0186-9","volume":"35","author":"B Wolska-Kusnierz","year":"2015","unstructured":"Wolska-Kusnierz B, Gregorek H, Chrzanowska K, Piatosa B, Pietrucha B, Heropolitanska-Pliszka E, et al. Nijmegen breakage syndrome: clinical and immunological features, long-term outcome and treatment options \u2013 a retrospective analysis. J Clin Immunol. 2015;35:538\u201349.","journal-title":"J Clin Immunol"},{"key":"955_CR63","doi-asserted-by":"crossref","DOI":"10.1136\/jmg.38.1.e3","volume":"38","author":"KH Chrzanowska","year":"2001","unstructured":"Chrzanowska KH, Stumm M, Bekiesiska-Figatowska M, Varon R, Biaecka M, Gregorek H, et al. Atypical clinical picture of the Nijmegen breakage syndrome associated with developmental abnormalities of the brain. J Med Genet. 2001;38:E3.","journal-title":"J Med Genet"},{"key":"955_CR64","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3389\/fimmu.2017.00807","volume":"8","author":"E Deripapa","year":"2017","unstructured":"Deripapa E, Balashov D, Rodina Y, Laberko A, Myakova N, Davydova NV, et al. Prospective Study of a Cohort of Russian Nijmegen Breakage Syndrome Patients Demonstrating Predictive Value of Low Kappa-Deleting Recombination Excision Circle (KREC) Numbers and Beneficial Effect of Hematopoietic Stem Cell Transplantation (HSCT). Front Immunol. 2017;8:807.","journal-title":"Front Immunol"},{"key":"955_CR65","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-0122","volume":"142","author":"H Marczak","year":"2018","unstructured":"Marczak H, Heropolita\u0144ska-Pliszka E, Langfort R, Roik D, Grzela K. Nijmegen breakage syndrome complicated with primary pulmonary granulomas. Pediatrics. 2018;142:e20180122.","journal-title":"Pediatrics"},{"key":"955_CR66","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1750-1172-7-13","volume":"7","author":"KH Chrzanowska","year":"2012","unstructured":"Chrzanowska KH, Gregorek H, Dembowska-Bagi\u0144ska B, Kalina MA, Digweed M. Nijmegen breakage syndrome (NBS). J Orphanet Rare Dis. 2012;7:13.","journal-title":"J Orphanet Rare Dis"},{"key":"955_CR67","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s10875-015-0136-6","volume":"35","author":"JP Patel","year":"2015","unstructured":"\u2022 Patel JP, Puck JM, Srinivasan R, Brown C, Sunderam U, Kundu K, et al. Nijmegen breakage syndrome detected by newborn screening for T cell receptor excision circles (TRECs). J Clin Immunol. 2015;35:227\u201333 A manuscript describing detection of newborn infants with NBS, picked up on newborn screening for SCID.","journal-title":"J Clin Immunol"},{"key":"955_CR68","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/pbc.21789","volume":"52","author":"B Dembowska-Baginska","year":"2009","unstructured":"Dembowska-Baginska B, Perek D, Brozyna A, Wakulinska A, Olczak-Kowalczyk D, Gladkowska-Dura M, et al. Non-Hodgkin lymphoma (NHL) in children with Nijmegen breakage syndrome (NBS). Pediatr Blood Cancer. 2009;52:186\u201390.","journal-title":"Pediatr Blood Cancer"},{"key":"955_CR69","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/bmt.2009.207","volume":"45","author":"MH Albert","year":"2010","unstructured":"Albert MH, Gennery AR, Greil J, Cale CM, Kalwak K, Kondratenko I, et al. Successful SCT for Nijmegen breakage syndrome. Bone Marrow Transplant. 2010;45:622\u20136.","journal-title":"Bone Marrow Transplant"},{"key":"955_CR70","doi-asserted-by":"crossref","unstructured":"Laberko A, Sultanova E, Gutovskaya E, Radygina S, Deripapa E, Kantulaeva A, et al. Treosulfan-based conditioning regimen in haematopoietic stem cell transplantation with TCR\u03b1\u03b2\/CD19 depletion in Nijmegen breakage syndrome. J Clin Immunol 2020 (in press).","DOI":"10.1007\/s10875-020-00811-9"},{"key":"955_CR71","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0960-9822(99)80311-X","volume":"9","author":"E Riballo","year":"1999","unstructured":"Riballo E, Critchlow SE, Teo SH, Doherty AJ, Priestley A, Broughton B, et al. Identification of a defect in DNA ligase IV in a radiosensitive leukaemia patient. Curr Biol. 1999;9:699\u2013702.","journal-title":"Curr Biol"},{"key":"955_CR72","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1172\/JCI26121","volume":"116","author":"M van der Burg","year":"2006","unstructured":"van der Burg M, van Veelen LR, Verkaik NS, Wiegant WW, Hartwig NG, Barendregt BH, et al. A new type of radiosensitive T-B-NK+ severe combined immunodeficiency caused by a LIG4 mutation. J Clin Invest. 2006;116:137\u201345.","journal-title":"J Clin Invest"},{"key":"955_CR73","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/eji.200535401","volume":"36","author":"D Buck","year":"2006","unstructured":"Buck D, Moshous D, de Chasseval R, Ma Y, le Deist F, Cavazzana-Calvo M, et al. Severe combined immunodeficiency and microcephaly in siblings with hypomorphic mutations in DNA ligase IV. Eur J Immunol. 2006;36:224\u201335.","journal-title":"Eur J Immunol"},{"key":"955_CR74","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.jaci.2008.08.031","volume":"122","author":"E Grunebaum","year":"2008","unstructured":"Grunebaum E, Bates A, Roifman CM. Omenn syndrome is associated with mutations in DNA ligase IV. J Allergy Clin Immunol. 2008;122:1219\u201320.","journal-title":"J Allergy Clin Immunol"},{"key":"955_CR75","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/ajmg.a.31644","volume":"143A","author":"N Toita","year":"2007","unstructured":"Toita N, Hatano N, Ono S, Yamada M, Kobayashi R, Kobayashi I, et al. Epstein-Barr virus-associated B-cell lymphoma in a patient with DNA ligase IV (LIG4) syndrome. Am J Med Genet A. 2007;143A:742\u20135.","journal-title":"Am J Med Genet A"},{"key":"955_CR76","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S1097-2765(01)00408-7","volume":"8","author":"M O'Driscoll","year":"2001","unstructured":"O'Driscoll M, Cerosaletti KM, Girard PM, Dai Y, Stumm M, Kysela B, et al. DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency. Mol Cell. 2001;8:1175\u201385.","journal-title":"Mol Cell"},{"key":"955_CR77","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3389\/fped.2018.00426","volume":"6","author":"AT Staines Boone","year":"2019","unstructured":"Staines Boone AT, Chinn IK, Alaez-Vers\u00f3n C, Yamazaki-Nakashimada MA, Carrillo-S\u00e1nchez K, Garc\u00eda-Cruz MLH, et al. Failing to Make Ends Meet: The Broad Clinical Spectrum of DNA Ligase IV Deficiency. Case Series and Review of the Literature. Front Pediatr. 2019;6:426.","journal-title":"Front Pediatr"},{"key":"955_CR78","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s10875-016-0266-5","volume":"36","author":"K Felgentreff","year":"2016","unstructured":"\u2022\u2022 Felgentreff K, Baxi SN, Lee YN, Dobbs K, Henderson LA, Csomos K, et al. Ligase-4 Deficiency Causes Distinctive Immune Abnormalities in Asymptomatic Individuals. J Clin Immunol. 2016;36:341\u201353 An important description of siblings to a patient with DNA ligase 4 deficiency who are asymptomatic despite harboring the same genetic mutation.","journal-title":"J Clin Immunol"},{"key":"955_CR79","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/humu.22461","volume":"35","author":"JE Murray","year":"2014","unstructured":"Murray JE, Bicknell LS, Yigit G, Duker AL, van Kogelenberg M, Haghayegh S, et al. Extreme growth failure is a common presentation of ligase IV deficiency. Hum Mutat. 2014;35:76\u201385.","journal-title":"Hum Mutat"},{"key":"955_CR80","doi-asserted-by":"crossref","unstructured":"Bacon CM, Wilkinson SJ, Spickett GP, Barge D, Lucraft HH, Jackson G, et al. Epstein-Barr virus-independent diffuse large B-cell lymphoma in DNA ligase 4 deficiency. J Allergy Clin Immunol 2013;131:1237\u20139, 1239.e1.","DOI":"10.1016\/j.jaci.2012.10.027"},{"key":"955_CR81","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.cell.2005.12.030","volume":"124","author":"D Buck","year":"2006","unstructured":"Buck D, Malivert L, de Chasseval R, Barraud A, Fondan\u00e8che M-C, Sanal O, et al. Cernunnos, a novel nonhomologous end-joining factor, is mutated in human immunodeficiency with microcephaly. Cell. 2006;124:287\u201399.","journal-title":"Cell"},{"key":"955_CR82","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.cell.2005.12.031","volume":"124","author":"P Ahnesorg","year":"2006","unstructured":"Ahnesorg P, Smith P, Jackson SP. XLF interacts with the XRCC4-DNA ligase IV complex to promote DNA nonhomologous end-joining. Cell. 2006;124:301\u201313.","journal-title":"Cell"},{"key":"955_CR83","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1073\/pnas.0437964100","volume":"100","author":"Y Dai","year":"2003","unstructured":"Dai Y, Kysela B, Hanakahi LA, Manolis K, Riballo E, Stumm M, et al. Nonhomologous end joining and V(D)J recombination require an additional factor. Proc Natl Acad Sci U S A. 2003;100:2462\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"955_CR84","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.clim.2015.06.009","volume":"161","author":"T Patiroglu","year":"2015","unstructured":"\u2022 Patiroglu T, Akar HH, van der Burg M, Kontas O. A Case of XLF Deficiency Presented With Diffuse Large B Cell Lymphoma in the Brain. Clin Immunol. 2015;161:394\u20135 First description of lymphoma in a patient with XLF deficiency.","journal-title":"Clin Immunol"},{"key":"955_CR85","first-page":"91","volume":"119","author":"M van der Burg","year":"2009","unstructured":"van der Burg M, Ijspeert H, Verkaik NS, Turul T, Wiegant WW, Morotomi-Yano K, et al. A DNA-PKcs mutation in a radiosensitive T-B- SCID patient inhibits Artemis activation and nonhomologous end-joining. J Clin Invest. 2009;119:91\u20138.","journal-title":"J Clin Invest"},{"key":"955_CR86","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1172\/JCI67349","volume":"123","author":"L Woodbine","year":"2013","unstructured":"Woodbine L, Neal JA, Sasi NK, Shimada M, Deem K, Coleman H, et al. PRKDC mutations in a SCID patient with profound neurological abnormalities. J Clin Invest. 2013;123:2969\u201380.","journal-title":"J Clin Invest"},{"key":"955_CR87","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.jaci.2015.01.040","volume":"135","author":"AL Mathieu","year":"2015","unstructured":"\u2022 Mathieu AL, Verronese E, Rice GI, Fouyssac F, Bertrand Y, Picard C, et al. PRKDC mutations associated with immunodeficiency, granuloma, and autoimmune regulator-dependent autoimmunity. J Allergy Clin Immunol. 2015;135:1578\u20131588.e5 A description of the expanding phenotype of DNA-PKcs deficiency.","journal-title":"J Allergy Clin Immunol"},{"key":"955_CR88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clim.2018.08.002","volume":"197","author":"S Esenboga","year":"2018","unstructured":"\u2022 Esenboga S, Akal C, Karaatmaca B, Erman B, Dogan S, Orhan D, et al. Two siblings with PRKDC defect who presented with cutaneous granulomas and review of the literature. Clin Immunol. 2018;197:1\u20135 A description of the expanding phenotype of DNA-PKcs deficiency.","journal-title":"Clin Immunol"},{"key":"955_CR89","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jaci.2018.05.028","volume":"143","author":"A Berland","year":"2019","unstructured":"\u2022 Berland A, Rosain J, Kaltenbach S, Allain V, Mahlaoui N, Melki I, et al. PROMIDIS\u03b1: A T-cell receptor \u03b1 signature associated with immunodeficiencies caused by V(D)J recombination defects. J Allergy Clin Immunol. 2019;143:325\u2013334.e2 A novel method of detecting VDJ recombination disorders by flow cytometry.","journal-title":"J Allergy Clin Immunol"},{"key":"955_CR90","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1385\/1-59259-973-7:073","volume":"314","author":"X Huang","year":"2006","unstructured":"Huang X, Darzynkiewicz Z. Cytometric assessment of histone H2AX phosphorylation: a reporter of DNA damage. Methods Mol Biol. 2006;314:73\u201380.","journal-title":"Methods Mol Biol"},{"key":"955_CR91","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1182\/bloodadvances.2018016113","volume":"2","author":"D Buchbinder","year":"2018","unstructured":"Buchbinder D, Smith MJ, Kawahara M, Cowan MJ, Buzby JS, Abraham RS. Application of a Radiosensitivity flow assay in a patient with DNA ligase 4 deficiency. Blood Adv. 2018;2:1828\u201332.","journal-title":"Blood Adv"},{"key":"955_CR92","doi-asserted-by":"crossref","DOI":"10.1017\/S1462399410001419","volume":"12","author":"MA Slatter","year":"2010","unstructured":"Slatter MA, Gennery AR. Primary immunodeficiencies associated with DNA-repair disorders. Expert Rev Mol Med. 2010;12:e9.","journal-title":"Expert Rev Mol Med"},{"key":"955_CR93","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/humu.23773","volume":"40","author":"A Fi\u00e9vet","year":"2019","unstructured":"\u2022 Fi\u00e9vet A, Bellanger D, Valence S, Mobuchon L, Afenjar A, Giuliano F, et al. Three New Cases of Ataxia-Telangiectasia-Like Disorder: No Impairment of the ATM Pathway, but S-phase Checkpoint Defect. Hum Mutat. 2019;40:1690\u20139 Description of more patients with ATLD.","journal-title":"Hum Mutat"},{"key":"955_CR94","doi-asserted-by":"crossref","first-page":"16479","DOI":"10.1074\/jbc.M312796200","volume":"279","author":"A L\u00e4hdesm\u00e4ki","year":"2004","unstructured":"L\u00e4hdesm\u00e4ki A, Taylor AMR, Chrzanowska KH, Pan-Hammarstr\u00f6m Q. Delineation of the role of the Mre11 complex in class switch recombination. J Biol Chem. 2004;279:16479\u201387.","journal-title":"J Biol Chem"},{"key":"955_CR95","first-page":"3708","volume":"24","author":"N Rosin","year":"2015","unstructured":"Rosin N, Elcioglu NH, Beleggia F, Isguven P, Altmuller J, Thiele H, et al. Mutations in XRCC4 cause primary microcephaly, short stature and increased genomic instability. Hum Mol Genet. 2015;24:3708\u201318.","journal-title":"Hum Mol Genet"},{"key":"955_CR96","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.ajhg.2015.01.013","volume":"96","author":"JE Murray","year":"2015","unstructured":"Murray JE, van der Burg M, Uspeert H, Carroll P, Wu Q, Ochi T, et al. Mutations in the NHEJ component XRCC4 cause primordial dwarfism. Am J Hum Genet. 2015;96:412\u201324.","journal-title":"Am J Hum Genet"},{"key":"955_CR97","doi-asserted-by":"crossref","first-page":"E789","DOI":"10.1210\/jc.2015-1098","volume":"100","author":"C de Bruin","year":"2015","unstructured":"de Bruin C, Mericq V, Andrew SF, van Duyvenvoorde HA, Verkaik NS, Losekoot M, et al. An XRCC4 splice mutation is associated with severe short stature, gonadal failure, and early-onset metabolic syndrome. J Clin Endocrinol Metab. 2015;100:E789\u201398.","journal-title":"J Clin Endocrinol Metab"},{"key":"955_CR98","doi-asserted-by":"crossref","first-page":"918","DOI":"10.15252\/emmm.201404803","volume":"7","author":"L Bee","year":"2015","unstructured":"Bee L, Nasca A, Zanolini A, Cendron F, d\u2019Adamo P, Costa R, et al. A nonsense mutation of human XRCC4 is associated with adult-onset progressive encephalocardiomyopathy. EMBO Mol Med. 2015;7:918\u201329.","journal-title":"EMBO Mol Med"},{"key":"955_CR99","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.jaci.2015.06.007","volume":"136","author":"C Guo","year":"2015","unstructured":"Guo C, Nakazawa Y, Woodbine L, Bj\u00f6rkman A, Shimada M, Fawcett H, et al. XRCC4 deficiency in human subjects causes a marked neurological phenotype but no overt immunodeficiency. J Allergy Clin Immunol. 2015;136:1007\u2013101.","journal-title":"J Allergy Clin Immunol"},{"key":"955_CR100","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.3389\/fimmu.2018.02912","volume":"9","author":"S Bomken","year":"2018","unstructured":"Bomken S, van der Werff Ten Bosch J, Attarbaschi A, Bacon CM, Borkhardt A, Boztug K, et al. Current Understanding and Future Research Priorities in Malignancy Associated With Inborn Errors of Immunity and DNA Repair Disorders: The Perspective of an Interdisciplinary Working Group. Front Immunol. 2018;9:2912.","journal-title":"Front Immunol"}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-020-00955-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11882-020-00955-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-020-00955-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T18:51:53Z","timestamp":1696359113000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11882-020-00955-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,9]]},"references-count":100,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["955"],"URL":"https:\/\/doi.org\/10.1007\/s11882-020-00955-z","relation":{},"ISSN":["1529-7322","1534-6315"],"issn-type":[{"value":"1529-7322","type":"print"},{"value":"1534-6315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,9]]},"assertion":[{"value":"9 July 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no conflicts of interest relevant to this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"57"}}